Trading Members and Custodians are requested to note that Securities Exchange Board of India (SEBI) has issued Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeover, Buy Back and De-listing vide its circular no. CIR/CFD/POLICYCELL/1/2015 dated April 13, 2015 and no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016. The Exchange vide its notice no. 20170210-16 dated Feb 10, 2017,20190424-35 dated April 24, 2019 and 20200528-32 dated 28 May 2020has issued Revised Guidelines of Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeovers, Buy Back and Delisting.
All Market Participants are hereby informed that a Cash Offer is made by ACESO COMPANY PTE. LTD (“Acquirer 1”), along with ACESO INVESTMENT HOLDINGS PTE. LTD (“PAC 1”), CVC CAPITAL PARTNERS ASIA V L.P (“PAC 2”), CVC CAPITAL PARTNERS INVESTMENT ASIA V L.P. (“PAC 3”), CVC CAPITAL PARTNERS ASIA V ASSOCIATES L.P. . (“PAC 4”), (herein collectively referred to as the “PACs”) to acquire up to 3,26,13,192 ( Three Crore Twenty Six Lakh Thirteen Thousand One Hundred and Ninety Two) equity shares representing 26.00% of the expanded voting share capital from the public shareholders of HEALTHCARE GLOBAL ENTERPRISES LIMITED (“Target Company”) at a price of Rs. 130 (Rupees One Hundred and Thirty) per fully paid up equity share of face value of Rs. 10 each (“Equity Shares”), pursuant to and in compliance with the provisions of Regulations 3(1), 4 and other applicable regulations of the SEBI (SAST) Regulations, from August 17,2020 to August 28,2020.
Market participants are further requested to note that this offer will be as per the Revised Guidelines of SEBI circular no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016 and Exchange notice no. 20170210-16 dated Feb 10, 2017 and 20190424-35 dated April 24, 2019 along with the details of this Offer to Buy would be available on BSE Website – www.bseindia.com.
Bhushan Mokashi
Additional General Manager
Listing Sales & Ops
August 13, 2020
|